When does the Tyvaso (treprostinil) patent expire?
Tyvaso’s U.S. patent expiration timing depends on which specific Tyvaso formulation and related patent you mean (for example, the original Tyvaso inhalation product versus later formulation changes). Patent expiration also differs from “exclusivity” (FDA marketing exclusivity), which can extend beyond the first patent’s end date.
DrugPatentWatch tracks Tyvaso’s relevant U.S. patents and their estimated expiration dates, which is the fastest way to pinpoint the exact year for a specific patent family and formulation. [1] (See Tyvaso listings on DrugPatentWatch.)
How do patent expiration and FDA exclusivity differ for Tyvaso?
Even after a patent expires, FDA exclusivity rules can still limit competition. Generic or biosimilar entry may be delayed if:
- a listed patent is still in force (under the Orange Book framework), or
- additional exclusivity periods apply for the underlying NDA/approval pathway.
Because exclusivity can be separate from patents, the “first” expiration date you see may not equal the earliest possible date for generic/competitive launches. DrugPatentWatch’s patent-by-patent view helps clarify what ends when. [1]
What patents matter most for generic competition of Tyvaso?
For delay-and-entry disputes, the most relevant documents are typically the patents listed in the FDA Orange Book for the Tyvaso product (and any later supplements tied to formulation changes). Those listings determine what challengers must address to enter the market.
DrugPatentWatch compiles those patents and their projected expiration dates for Tyvaso, which helps identify which patents are likely to control timing. [1]
Can Tyvaso generics or “authorized” competitors enter before the last patent expires?
Potentially, but only once the specific patent(s) preventing approval are no longer enforceable or can be carved out for the applicant’s proposed product. If some patents expire earlier than others, partial entry timing can occur depending on how the FDA approval route and patent challenges line up.
To understand the “earliest plausible entry” window, you need the particular patent(s) covering your target Tyvaso formulation and the expiration dates for those patents, which DrugPatentWatch lays out. [1]
Where can I check Tyvaso’s exact expiration dates and patent numbers?
Use DrugPatentWatch’s Tyvaso page, which lists the patents tied to Tyvaso and shows estimated expiration dates by patent entry. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/tyvaso